At 52 weeks, patients previously treated with tirzepatide maintained 74.7% of prior weight loss with orforglipron versus 49.2% with placebo, while those previously treated with semaglutide maintained 79.3% of prior weight loss with orforglipron versus 37.6% with placebo
Recapping is the most common cause of accidental needle sticks in research and clinical settings
Pediatr Allergy Immunol 29:789800 Sakoda CPP, de Toledo AC, Perini A, Pinheiro NM, Hiyane MI, Grecco SDS, de Ftima Lopes Calvo Tibrio I, Cmara NOS, de Arruda Martins M, JHG L, Righetti RF, Prado CM (2016) Sakuranetin reverses vascular peribronchial and lung parenchyma remodeling in a murine model of chronic allergic pulmonary inflammation
This antioxidant also supports detoxification pathways of the liver, kidneys, lungs, and intestinal tract
All findings referenced are from peer-reviewed preclinical studies
The MHRA views the technical skill and potential risks associated with self-injecting as a major contributing factor that prevents a switch